Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Shares Outstanding (2011 - 2026)

Updated

Grace Therapeutics (GRCE) recorded Weighted Average Shares Outstanding of 20.12 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), up 26.3% from 15.92 million a year earlier and up 16.5% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Shares Outstanding (2011 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Grace Therapeutics reported Weighted Average Shares Outstanding of 16.51 million, up 36.6% from FY2025.

  • Annual Weighted Average Shares Outstanding has increased for eight straight fiscal years, with a five-year compound annual growth rate of 46.2% (FY2021 to FY2026).
  • Across earlier fiscal years, Weighted Average Shares Outstanding came in at 12.09 million in FY2025 (+26.8%), 9.53 million in FY2024 (+28.2%), 7.44 million in FY2023 (+21.1%) and 6.14 million in FY2022 (+148.5%).
  • The fiscal Q2 2027 figure is the highest quarterly Weighted Average Shares Outstanding in data going back to fiscal Q1 2012.
  • On a year-over-year basis, Weighted Average Shares Outstanding has increased for seven consecutive quarters, with growth averaging 28.7% over the last eight quarters.
  • The year-over-year growth in Weighted Average Shares Outstanding has ranged between 0.0% (fiscal Q3 2025) and 220.7% (fiscal Q3 2022) over the last five years.
  • Per Business Quant, the preceding three fiscal quarters came in at 17.27 million (Q1 2027), 16.51 million (Q4 2026) and 16.93 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 891.90 Mn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 2.41 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 1.77 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 2.47 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - 1.94 Bn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 1.55 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 541.00 Mn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 1.24 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 5.70 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn - 20.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 20.12 Mn
Jun 30, 2026 17.27 Mn
Mar 31, 2026 16.51 Mn
Dec 31, 2025 16.93 Mn
Sep 30, 2025 15.92 Mn
Jun 30, 2025 15.92 Mn
Mar 31, 2025 12.09 Mn
Dec 31, 2024 11.51 Mn
Sep 30, 2024 11.51 Mn
Jun 30, 2024 10.93 Mn
Mar 31, 2024 9.53 Mn
Dec 31, 2023 11.51 Mn
Sep 30, 2023 7.55 Mn
Jun 30, 2023 7.44 Mn
Mar 31, 2023 7.44 Mn
Dec 31, 2022 7.44 Mn
Sep 30, 2022 7.43 Mn
Jun 30, 2022 7.39 Mn
Mar 31, 2022 6.14 Mn
Dec 31, 2021 7.38 Mn
API Access

Grace Therapeutics Shares Outstanding API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding&ticker=GRCE&period=max&api_key=YOUR_API_KEY